Angela Spivey comments on why the cannabis industry should not expect immediate action by the U.S. Food and Drug Administration to allow cannabidiol in regulated products.
In the News
June 2, 2019
Food Navigator | ‘The Prevalence of Questionable Products May Inspire a Tsunami of Class Action Litigation…’ the Regulatory Path Forward for CBD
Media Contact